Published on in Vol 11 (2025)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/63964, first published
.

Journals
- Segura J, Zavaleta E, Jiménez J, Mora K. Opinion paper: artificial intelligence in cardio-oncology: a clinical call to action. Frontiers in Oncology 2025;15 View
- Migliari M, Fazzini L, Campana N, Deidda M, Dessì M, Cadeddu Dessalvi C. Current strategies for prevention of cancer therapy-related cardiotoxicity: pharmacological, non-pharmacological and emerging approaches. Frontiers in Cardiovascular Medicine 2025;12 View
- Gianchandani P, Zhang L. The Role of Artificial Intelligence in Cardio-Oncology. Current Cardiovascular Imaging Reports 2025;18(1) View
- Lim H, Ryan T, Miller E, Shea E, Bansal N. Cardiovascular Care in Pediatric Cancer Survivors: Updates on Risk, Prevention, and Therapies. Current Treatment Options in Oncology 2026;27(1) View
- Maini A, Zaha V. A New Era of Biomarkers in Cardio-Oncology. Current Treatment Options in Cardiovascular Medicine 2026;28(1) View
- Oisakede E, Oyedeji O, Olawuyi O, Alabi J, Daniel R, Olawade D. Nanoparticle-mediated cardiotoxicity and nanomedicine interventions in cancer treatment. Nano TransMed 2026;5:100113 View
- Ma Z, Caldwell R, Attia Z, Friedman P, Lerman A, Ng C, Herrmann J. Harnessing artificial intelligence for cardio-oncology:Towards a new future of cardiovascular care for the cancer patient. Trends in Cardiovascular Medicine 2026;36(6):389 View
- Afana A, Goncalves T, Toupin S, Pezel T. Artificial intelligence in cardiovascular imaging: current practice in cardio-oncology. Romanian Journal of Cardiology 2026;36(1):19 View
- Heydari F, Feli M, Maleknia M, Habibi Z, Sohrabi A, Hamblin M, Naghinezhad J. Beyond Remission: The Cardiotoxic and Thrombotic Shadow of AML Chemotherapy. Cardiovascular Toxicology 2026;26(3) View
- Avagimyan A, Pogosova N, Cardinale D, Fogacci F, Djndoyan Z, Mkrtchyan L, Rezabakhsh A, Cicero A, Faggiano A, Gherbesi E, Carugo S, Taheri M, Bernardi M, Spadafora L, Sasso L, Perone F, Shafie D, Rizzo M, Alizadehasl A, Moudgil R, Sabouret P, Sverdlov A, Prattichizzo F, Ceriello A, Biondi-Zoccai G, Madonna R, De Caterina R, Asteggiano R, Sarrafzadegan N. Diagnostics in cardio-oncology: a focus on anthracyclines. Heart Failure Reviews 2026;31(1) View
- Ayalew B, Haq M, Farooq T, Mubarika M, Umar M, Shafique U, Rehman A, Eladl H, Toor A, Fatima E, Sharew T, Baig M, Smith D, Addison D. Precision Cardio-Oncology and Nuclear Imaging: Current Applications, Molecular Innovations, and Future Trajectories. Cancers 2026;18(10):1625 View
- Iaconelli A, Scacciavillani R, Cacioli L, Pecorini G, Kretzler L, Anker M. From Cardioprotection to Trial Design: Rethinking Cardiac Safety in Oncology. Current Heart Failure Reports 2026;23(1) View
- Rakisheva A, Disabato G, Abreu A, Attanasio A, Bauersachs J, Becker M, Callewaert B, Castelo-Branco C, Castelvecchio S, De Backer J, Grapsa J, Guida G, Haugaa K, Keramida K, Neubeck L, Nappi R, Price S, Regitz-Zagrosek V, Roos-Hesselink J, Sliwa K, Soloveva A, Sudano I, Piepoli M. Prevention of heart failure in women: an expert consensus statement on sex-specific risk factors. European Journal of Heart Failure 2026 View
- Rech L. From Automated ECG Interpretation to Multimodal Cardiovascular Intelligence: The Evolution of Artificial Intelligence in Cardiovascular Medicine. Medical Sciences 2026;14(4):434 View
- Anosike U, Olunga R, Korir E, Etumudon S, Brezden-Masley C, Wakeam E, Lukovic J, Yan M, Zafar A, Abdel-Qadir H. Resectable Esophageal Cancer Therapy-Related Cardiac Dysfunction: A Review of Mechanisms and Predictive Tools. Foregut: The Journal of the American Foregut Society 2026 View
- Akrawi D, Datta S, Hatipoglu S, Wechalekar A, Ghose A, Alkhateeb A, Walker J, Ghosh A. Cardiovascular Care in Multiple Myeloma: A Comprehensive Review and Integrated Systems-Based Approach from a UK Cardio-Oncology Centre of Excellence. Current Cardiology Reports 2026;28(1) View
- Wu L, Le-Dang M, Okoye B, Park C. Machine learning-based prediction of cardiovascular adverse events in patients with cancer: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 2026:1 View
